Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP)
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations
Clin Ophthalmol 2022 Apr 01;16(2022)765-774, LA Bonnet, RM Conway, LA LimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.